13 February 2025
13 February 2025
Speaking publicly for the first time about the USAID freeze, Dr Tedros has asked the US to reconsider its position.
GlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.
The funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.
Xilio will obtain upfront payments totalling $52m and including a $10m equity investment.
The new entity will leverage TriNetX's LIVE platform, which encompasses a network of 200 million patient records.
The deal comes as Biogen reports its Q4 2024 earnings.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
